Atai Beckley - Public Comps and Valuation Multiples

Atai Beckley Overview

About Atai Beckley

Atai Beckley NV is a clinical-stage biopharmaceutical company. It aims to develop mental health treatments to transform patient outcomes. The company's pipeline of psychedelic-based therapies includes VLS-01 and BPL-003 for the treatment-resistant depression (TRD) and EMP-01 (oral R-MDMA) for social anxiety disorder.

Founded

2020

HQ

Employees

Website

ataibeckley.com

Sectors

Drug Development & Therapeutics
BioTech

Financials

LTM Revenue $3.0M

LTM EBITDA -$101M

EV

$1.3B

Valuation Multiples

Multiples.vc

Valuation Multiples for 15K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Browse Valuation Multiples

Atai Beckley Financials

As of December 2025, Atai Beckley reported last 12-month revenue of $3.0M and EBITDA of -$101M.

In the same period, Atai Beckley achieved -$144M in LTM net income.

See Atai Beckley valuation multiples based on analyst estimates

Atai Beckley P&L

In the most recent fiscal year, Atai Beckley reported revenue of $0.3M and EBITDA of -$145M.

Atai Beckley expects next 12-month revenue of XXX and NTM EBITDA of XXX

See Atai Beckley valuation multiples based on analyst estimates

	LTM	NTM	Last FY	FY 2026	FY 2027	FY 2028
Revenue	$3.0M	XXX	$0.3M	XXX	XXX	XXX
Gross Profit	n/a	XXX	n/a	XXX	XXX	XXX
Gross Margin	n/a	XXX	n/a	XXX	XXX	XXX
EBITDA	-$101M	XXX	-$145M	XXX	XXX	XXX
EBITDA Margin	-3367%	XXX	-47016%	XXX	XXX	XXX
EBIT	-$103M	XXX	-$102M	XXX	XXX	XXX
EBIT Margin	-3439%	XXX	-33171%	XXX	XXX	XXX
Net Profit	-$144M	XXX	-$149M	XXX	XXX	XXX
Net Margin	-4802%	XXX	-48464%	XXX	XXX	XXX
Net Debt	XXX	XXX	$6.0M	XXX	XXX	XXX

Financial data powered by Morningstar, Inc.

.seo-only-financials-wrapper { position: static; left: auto; width: auto; height: auto; overflow: visible; }

Financial performance metrics for Atai Beckley including revenue, profitability, and margin analysis across different time periods. The company reported last twelve months revenue of $3.0M. EBITDA for the last twelve months was -$101M. In the most recent fiscal year, Atai Beckley achieved $0.3M in revenue and -$145M in EBITDA.
Financial Metric	Last Twelve Months (LTM)	Next Twelve Months (NTM)	Most Recent Fiscal Year	Current Fiscal Year (2026)	Next Fiscal Year (2027)	Two Years Forward (2028)
Total Revenue	$3.0M	Analyst estimates available to subscribers	$0.3M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit	n/a	Analyst estimates available to subscribers	n/a	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit Margin	n/a	Analyst estimates available to subscribers	NaN% gross profit margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA (Earnings Before Interest, Taxes, Depreciation, Amortization)	-$101M	Analyst estimates available to subscribers	-$145M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA Margin	-3366.9% EBITDA margin	Analyst estimates available to subscribers	-47015.6% EBITDA margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT (Earnings Before Interest and Taxes)	-$103M	Analyst estimates available to subscribers	-$102M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT Margin	-3439.5% EBIT margin	Analyst estimates available to subscribers	-33170.8% EBIT margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Income (Net Profit)	-$144M	Analyst estimates available to subscribers	-$149M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Profit Margin	-4801.8% net profit margin	Analyst estimates available to subscribers	-48464.0% net profit margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Debt Position	Detailed debt information available to subscribers	Detailed debt information available to subscribers	$6.0M	Detailed debt information available to subscribers	Detailed debt information available to subscribers	Detailed debt information available to subscribers

Financial Performance Summary for Atai Beckley

This financial data table provides comprehensive performance metrics for Atai Beckley, a company based in United States of America. The metrics include revenue, profitability measures, and operational efficiency indicators across multiple time periods.

Recent Performance Highlights

Atai Beckley generated $3.0M in revenue over the last twelve months.
The company achieved -$101M in EBITDA over the last twelve months.
Net income over the last twelve months reached -$144M.

Fiscal Year Performance

In the most recent fiscal year, Atai Beckley reported $0.3M in total revenue.
Fiscal year EBITDA was -$145M.
The company maintained a gross profit margin of NaN% in the most recent fiscal year.
EBITDA margin for the fiscal year was -47015.6%.
Net profit margin reached -48464.0% in the most recent fiscal year.

This financial data is sourced from Morningstar, Inc. and represents the most recent available information for Atai Beckley. Forward-looking estimates and detailed financial projections are available through our premium subscription service.

Atai Beckley Stock Performance

Atai Beckley has current market cap of $1.4B, and EV of $1.3B.

Market Cap Evolution

Atai Beckley Stock Data

As of January 9, 2026, Atai Beckley's stock price is $4.

See Atai Beckley trading valuation data

EV	Market Cap	Price 1D	Price 1M	Price 3M	Price 12M	EPS
$1.3B	$1.4B	XXX	XXX	XXX	XXX	$-0.64

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Start Free Trial

Atai Beckley Valuation Multiples

Atai Beckley's trades at 416.0x EV/Revenue multiple, and -12.4x EV/EBITDA.

See valuation multiples for Atai Beckley and 15K+ public comps

Atai Beckley Financial Valuation Multiples

As of January 9, 2026, Atai Beckley has market cap of $1.4B and EV of $1.3B.

Equity research analysts estimate Atai Beckley's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

Atai Beckley has a P/E ratio of -9.4x.

	LTM	NTM	Last FY	FY 2026	FY 2027	FY 2028
Market cap (current)	$1.4B	XXX	$1.4B	XXX	XXX	XXX
EV (current)	$1.3B	XXX	$1.3B	XXX	XXX	XXX
EV/Revenue	416.0x	XXX	416.0x	XXX	XXX	XXX
EV/EBITDA	-12.4x	XXX	-12.4x	XXX	XXX	XXX
EV/EBIT	-12.1x	XXX	-12.1x	XXX	XXX	XXX
EV/Gross Profit	n/a	XXX	n/a	XXX	XXX	XXX
P/E	-9.4x	XXX	-9.4x	XXX	XXX	XXX
EV/FCF	-14.9x	XXX	-14.9x	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Atai Beckley Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Start Free Trial

Atai Beckley Margins & Growth Rates

Atai Beckley's last 12 month revenue growth is -85%

Atai Beckley's revenue per employee in the last FY averaged $5K, while opex per employee averaged $1.6M for the same period.

Atai Beckley's rule of 40 is -11649% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Atai Beckley's rule of X is -3579% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

See operational valuation multiples for Atai Beckley and other 15K+ public comps

Atai Beckley Operational Valuation Multiples

	LTM	NTM	Last FY	FY 2026	FY 2027	FY 2028
Revenue Growth	-85%	XXX	-48%	XXX	XXX	XXX
EBITDA Margin	-3367%	XXX	-3367%	XXX	XXX	XXX
EBITDA Growth	31%	XXX	n/a	XXX	XXX	XXX
Rule of 40	-11649%	XXX	-3452%	XXX	XXX	XXX
Bessemer Rule of X	XXX	XXX	-3579%	XXX	XXX	XXX
Revenue per Employee	XXX	XXX	$5K	XXX	XXX	XXX
Opex per Employee	XXX	XXX	$1.6M	XXX	XXX	XXX
S&M Expenses to Revenue	XXX	XXX	n/a	XXX	XXX	XXX
G&A Expenses to Revenue	XXX	XXX	n/a	XXX	XXX	XXX
R&D Expenses to Revenue	XXX	XXX	18005%	XXX	XXX	XXX
Opex to Revenue	XXX	XXX	33271%	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics

Pharma Analytics

Private Equity

ERP Software

Developer Tools

Consumer SaaS

Streaming Platforms

Explore Valuation Multiples by Industry

Start Free Trial